Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer
Anticancer Research · 2025
DOI: 10.21873/anticanres.17751 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, 2025. Verfasst von Hiroshi Shimizu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan. Hauptthemen laut MEDLINE: Pancreatic Neoplasms, Circulating Tumor DNA, Proto-Oncogene Proteins p21(ras), Mutation.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan.
- Department of Gastroenterology, Fukushima Medical University School of Medicine, Fukushima, Japan subaru@fmu.ac.jp.
Zitieren
APA
Shimizu, H., Suzuki, R., Asama, H., Sugimoto, M., Sato, K., Osawa, K., Ohira, R., & Ohira, H. (2025). Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer. Anticancer Research. https://doi.org/10.21873/anticanres.17751
Vancouver
Shimizu H, Suzuki R, Asama H, Sugimoto M, Sato K, Osawa K, et al. Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer. Anticancer Research. 2025. doi:10.21873/anticanres.17751
BibTeX
@article{Shimizu2025,
author = {Shimizu, Hiroshi and Suzuki, Rei and Asama, Hiroyuki and Sugimoto, Mitsuru and Sato, Kentaro and Osawa, Kento and Ohira, Rei and Ohira, Hiromasa},
title = {Prediction System for KRAS Mutation Detection in Circulating Tumor DNA in Unresectable Pancreatic Cancer},
journal = {Anticancer Research},
year = {2025},
doi = {10.21873/anticanres.17751}
}
EUVIMED